The Board remands the claim for a neurocognitive disorder, to include unspecified neurocognitive disorder and early onset Alzheimer's disease, due to insufficient evidence in the December 2023 VA examination.
The deciding factor: The December 2023 VA examination is found inadequate as it did not conduct necessary neuropsychological testing and ignored submitted medical literature supporting a potential link between toxic exposure and neurocognitive disorders.
- Claimed conditions
- Neurocognitive disorder, Unspecified neurocognitive disorder, Early onset Alzheimer's disease
- How they argued it
- Direct service connection
- Exposure basis
- Camp Lejeune water
- Rating assigned
- None in this decision
- Decision date
- November 12, 2025
- Citation
- A25098242
Veterans Law Judge
Decisions by this judge: 2,316 · Granted: 43% (granted or partly granted, in the vetted decisions on this site)
Judge attribution: 2025 complete; earlier years partial.
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Look up the original decision on VA.gov (opens in a new tab) using citation A25098242.
What this means for you
A remand is not a loss. The Board sent the case back for more development — often a new exam or missing records — before making a final decision. Many remands later end in a grant, and the decision spells out exactly what the Board wanted to see.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Granted
The Veteran's death was caused by difluoroethane poisoning, which is deemed an accident. The Board found that the cause of death is proximately due to his service-connected major depressive disorder with anxious distress and neurocognitive disorder.
- Remanded (sent back)
The Board has remanded the case due to a failure of VA's duty to assist, specifically regarding the lack of a toxic exposure risk activity (TERA) opinion for the Veteran's major vascular neurocognitive disorder with behavioral disturbance. The claim will be reconsidered in light of this new information.
- Granted
The Veteran's unspecified anxiety disorder and neurocognitive disorder are rated at 70 percent, effective November 8, 2023. The decision also grants entitlement to a TDIU based on a single disability.
- Granted
The Board has granted service connection for a mild neurocognitive disorder as secondary to the Veteran's service-connected multiple sclerosis.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.